Annals of Hematology

, Volume 62, Issue 6, pp 203–210 | Cite as

Interleukin-6 in clinical medicine

  • J. Bauer
  • F. Herrmann
Review Article


This article covers the basic biological functions of interleukin-6 (IL-6) in man. Three major topics are addressed more closely: the involvement of IL-6 in various disease states, particularly those of hematopoietic origin; the diagnostic usefulness of IL-6 measurements in biological fluids; the possible use of IL-6, IL-6 antagonists or IL-6 derivatives as therapeutic means.

Key words

Interleukin-6 Inflammation Acute phase response Hematopoiesis leukemia Tumor 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aarden LA, De Groot ER, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17: 1411–1416Google Scholar
  2. 2.
    Akira S, Hirano T, Taga T, Kishimoto T (1990) Biology of multifunctional cytokines: IL-6 and related molecules. FASEB J 4: 2860–2867Google Scholar
  3. 3.
    Andus T, Gross V, Cäsar J, Krumm D, Hosp J, David M, Schölmerich J (1991) Activation of monocytes during inflammatory bowel disease. Pathobiol (in press)Google Scholar
  4. 4.
    Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y, Shibuya A, Hirano T, Kishimoto T, Takaku F, Akiyama Y (1990) In vivo effects of recombinant human interleukin-6 in primates: stimulated production of plate-lets. Blood 75: 1602–1605Google Scholar
  5. 5.
    Asaoku H, Kawano M, Iwato K, Tanabe O, Tanaka H, Hirano T, Kishimoto T, Kuramoto A (1988) Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma. Blood 72: 429–432Google Scholar
  6. 6.
    Bataille R, Jourdan M, Zhang XG, Klein B (1989) Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias. J Clin Invest 84: 2008–2010Google Scholar
  7. 7.
    Bauer J (1989) Interleukin-6 and its receptor during homeostasis, inflammation, and tumor growth. Klin Wochenschr 67: 697–706Google Scholar
  8. 8.
    Bauer J, Ganter U, Geiger T, Jacobshagen U, Hirano T, Matsuda T, Kishimoto T, Andus T, Acs G, Gerok W, Ciliberto G (1988) Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood 72: 1134–1140Google Scholar
  9. 9.
    Bauer J, Bauer TM, Kalb T, Taga T, Lengyel G, Hirano T, Kishimoto T, Acs G, Mayer L, Gerok W (1989) Regulation of interleukin-6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J Exp Med 170: 1537–1549Google Scholar
  10. 10.
    Bender S, Haubeck HD, Van de Leur E, Dufhues G, Schiel X, Lauweriins J, Greiling H, Heinrich PC (1990) Interleukin-1 β induces synthesis and secreation of interleukin-6 in human chondrocytes. FEBS Lett 263: 321–324Google Scholar
  11. 11.
    Bhardwaj N, Santhanam U, Lau LL, Tatter SB, Ghrayeb J, Rivels M, Steinmann RM, Sehgal PB, May LT (1989) IL-6/IFNβ2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. J Immunol 143: 2153–2159Google Scholar
  12. 12.
    Biondi A, Rossi V, Bassan R, Barbui T, Bettoni S, Sironi M, Mantovani A, Rambaldi A (1989) Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 73: 1279–1284Google Scholar
  13. 13.
    Bodine D, Karlsson S, Nienhuis AW (1989) Combination of interleukin-3 and -6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hemopoietic stem cells. Proc Natl Acad Sci USA 86: 8897–8901Google Scholar
  14. 14.
    Bot FJ, van Eijk L, Broeders L, Aarden LA, Löwenberg B (1989) Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells. Blood 73: 135–137Google Scholar
  15. 15.
    Brach MA, Löwenberg B, Mantovani L, Schwulera U, Brennscheidt U, Mertelsmann R, Herrmann F (1990) Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts. Blood 76: 1972–1979Google Scholar
  16. 16.
    Brach MA, Cicco NA, Riedel D, Hirano T, Kishimoto T, Mertelsmann RH, Herrmann F (1990) Mechanisms of differential regulation of interleukin-6 mRNA accumulation by tumor necrosis factor alpha and lymphotoxin during monocytic differentiation. FEBS Lett 263: 349–354Google Scholar
  17. 17.
    Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW (1990) Dysregulated interleukin-6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 86: 592–599Google Scholar
  18. 18.
    Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, Martinez-Maza O (1990) Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 144: 480–484Google Scholar
  19. 19.
    Broukaert P, Spriggs DR, Demetri G, Kufe DW, Fiers W (1989) Circulating interleukin-6 during a continuous infusion of tumor necrosis factor and interferon gamma. J Exp Med 169: 2257–2262Google Scholar
  20. 20.
    Caracciolo D, Clark SC, Rovera G (1989) Human interleukin-6 supports granulocyte differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF. Blood 73: 666–670Google Scholar
  21. 21.
    Chen L, Novick D, Rubinstein M, Revel M (1988) Recombinant interferon-β2 (interleukin-6) induces myeloid differentiation. FEBS Lett 239: 299–304Google Scholar
  22. 22.
    Chen L, Mory Y, Zilberstein A, Revel M (1988) Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon β2. Proc Natl Acad Sci USA 85: 8037–8041Google Scholar
  23. 23.
    Chiu CP, Lee F (1989) IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells. J Immunol 142: 1909–1915Google Scholar
  24. 24.
    Cicco NA, Lindemann A, Content J, Vandenbussche P, Lübbert M, Gauss J, Mertelsmann R, Herrmann F (1989) Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood 75: 2049–2052Google Scholar
  25. 25.
    Everson MP, Brown CB, Lilly MB (1989) Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells. Blood 74: 1472–1476Google Scholar
  26. 26.
    Fiedler W, Weh HJ, Sucin E, Wittlief C, Stocking C, Hossfeld DK (1990) The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma. Leukemia 4: 462–465Google Scholar
  27. 27.
    Fong Y, Moldawer LL, Marano M, Wei H, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF (1989) Endotoxemia elicits increased circulating IFN-β2/IL-6 in man. J Immunol 142: 2321–2324Google Scholar
  28. 28.
    Freeman GJ, Freedman AS, Rabinowe SN, Segil JM, Horowitz J, Rosen K, Whitman JF, Nadler LM (1989) Interleukin-6 gene expression in normal and neoplastic B cells. J Clin Invest 83: 1512–1518Google Scholar
  29. 29.
    Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A (1989) On the cellular source and function of interleukin-6 in the central nervous system in viral disease. Eur J Immunol 19: 689–694Google Scholar
  30. 30.
    Ganter U, Arcone R, Toniatti C, Ciliberto G (1989) Dual control of CRP gene expression by interleukin-1 and interleukin-6. EMBO J 8: 3773–3779Google Scholar
  31. 31.
    Garman RD, Jacobs KA, Clark SC, Raulet DH (1987) B-cellstimulatory factor 2 (β2-interferon) functions as a second signal for interleukin-2 production by mature murine T cells. Proc Natl Acad Sci USA 84: 7629–7633Google Scholar
  32. 32.
    Grau GE (1990) Implications of cytokines in immunopathology: experimental and clinical data. Eur Cytokine Net 1: 203–210Google Scholar
  33. 33.
    Grossmann RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB (1989) Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367–6371Google Scholar
  34. 34.
    Guerne PA, Carson DA, Lotz M (1990) IL-6 production by human articular chondrocytes. J Immunol 144: 499–505Google Scholar
  35. 35.
    Hack CE, De Groot ER, Felt-Bersma RJF, Nuijens JH, Van Schijndel RJM, Eerenberg-Belmer AJM, Thijs LG, Aarden LA (1989) Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704–1710Google Scholar
  36. 36.
    Helfgott DC, Tatter SB, Santhanam U, Clarick RH, Bhardwaj N, May LT, Sehgal PB (1989) Multiple forms of IFN-β2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 142: 948–953Google Scholar
  37. 37.
    Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T (1990) Molecular cloning and expression of an IL-6 signal transducer, gp 130. Cell 63: 1149–1157Google Scholar
  38. 38.
    Hill RJ, Warren MK, Levin J (1990) Stimulation of thrombopoiesis in mice by human recombinant interleukin-6. J Clin Invest 85: 1242–1247Google Scholar
  39. 39.
    Hirano T (1990) Interleukin-6 in immune response and hematopoiesis. In: Mertelsmann R, Herrmann F (eds) Hematopoietic growth factors in clinical applications. Marcel Dekker, New York, pp 471–488Google Scholar
  40. 40.
    Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, Kishimoto T (1985) Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSF-2). Proc Natl Acad Sci USA 82: 5490–5494Google Scholar
  41. 41.
    Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T (1987) Human B-cell differentiation factor defined by antipeptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 84: 228–231Google Scholar
  42. 42.
    Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, Kishimoto T (1988) Excessive production of interleukin-6/B-cell-stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 1797–1801Google Scholar
  43. 43.
    Hoang T, Haman A, Goncalves O, Wong GG, Clark SC (1988) Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia. Blood 72: 823–826Google Scholar
  44. 44.
    Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fuji Y, Dohi K, Ishikawa H, Ohomoto Y, Yoshizaki K, Hirano T, Kishimoto T (1989) Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143: 3949–3955Google Scholar
  45. 45.
    Houssiau FA, Bukasa K, Sindic CJM, Van Damme J, Van Snick J (1988) Elevated levels of the 26-K human hybridoma growth factor (interleukin-6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol 71: 320–323Google Scholar
  46. 46.
    Houssiau FA, Coulie PG, Olive D, Van Snick J (1988) Synergistic activation of human T cells by interleukin-1 and interleukin-6. Eur J Immunol 18: 653–656Google Scholar
  47. 47.
    Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M (1987) Interleukin-6 enhancement of interleukin-3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 84: 9035–9039Google Scholar
  48. 48.
    Ishibashi T (1989) Kimura H, Uchida T, Kariyone S, Friese P, Burstein SA (1989) Human interleukin-6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86: 5953–5957Google Scholar
  49. 49.
    Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatsuki F, Akiyama Y (1989) Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74: 1241–1244Google Scholar
  50. 50.
    Ishikawa H, Tanaka H, Iwato K, Tanabe O, Assaoku H, Nobuyoshi M, Yamamoto I, Kawano M, Kuramoto A (1990) Effect of glucocorticoids on the biological activities of myeloma cells: inhibition of interleukin-1β osteoclast activating factorinduced bone resorption. Blood 75: 715–720Google Scholar
  51. 51.
    Ishimi Y, Miyaura L, Jin C, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145: 3297–3303Google Scholar
  52. 52.
    Jablons DM, Mule JJ, McIntosh JK, Sehgal PB, May LT, Huang CM, Rosenberg SA, Lotze MT (1989) IL-6/IFNβ2 as a circulating hormone. Induction by cytokine administration. J Immunol 142: 1542–1547Google Scholar
  53. 53.
    Jourdan M, Bataille R, Seguin J, Zhang XG, Chaptal PA, Klein B (1990) Constitutive production of interleukin-6 and immunologic features in cardiac myxoma. Arthritis Rheum 33: 398–403Google Scholar
  54. 54.
    Kato K, Yokoi T, Takano N, Kanegane H, Yachie A, Miyawaki T, Taniguchi N (1990) Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood. J Immunol 144: 1317–1322Google Scholar
  55. 55.
    Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83–85Google Scholar
  56. 56.
    Kirnbauer R, Köck A, Schwarz T, Urbanski A, Krutmann J, Borth W, Damm D, Shipley G, Ansel JC, Luger TA (1989) IFNβ2, BSF-2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 142: 1922–1928Google Scholar
  57. 57.
    Kishimoto T (1989) The biology of interleukin-6. Blood 74: 1–10Google Scholar
  58. 58.
    Klein B, Zhang XG, Jourdan M, Content J, Houssian F, Aarden L, Piechaczyk M, Bataille R (1989) Paracrine rather than autocrine regulation of myeloma — cell growth and differentiation by IL-6. Blood 73: 517–526Google Scholar
  59. 59.
    Klein B, Zhang XG, Jourdan M, Boiron JM, Portier M, Lu ZY, Wijdenes J, Brochier J, Bataille R (1990) Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur Cytokine Net 1: 193–201Google Scholar
  60. 60.
    Klein H, Becher R, Lübbert M, Oster W, Schleiermacher E, Brach MA, Souza L, Lindemann A, Mertelsmann R, Herrmann F (1990) Synthesis of granulocyte colony-stimulating factor and its requirement for terminal divisions in chronic myelogenous leukemia. J Exp Med 171: 1785–1790Google Scholar
  61. 61.
    Koike K, Nakahata T, Kikuchi T, Takagi M, Ishiguro A, Tsuji K, Naganuma K, Okano A, Akiyama T (1990) Interleukin-6 enhances murine megakaryocytopoiesis in serum-free culture. Blood 75: 2286–2291Google Scholar
  62. 62.
    Krutman J, Elmets CA (1988) Recent studies on mechanisms in photoimmunology. Photochem Photobiol 48: 787–798Google Scholar
  63. 63.
    Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD (1990) IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release. J Immunol 144: 4226–4230Google Scholar
  64. 64.
    Lansdorp PM, Aarden LA, Calafat J, Zeiljemaker WP (1986) A growth-factor-dependent B-cell hybridoma. Curr Top Microbiol Immunol 132: 105–113Google Scholar
  65. 65.
    Lee JD, Swisher SG, Minehart EH, Mc Bride WH, Economou JS (1990) Interleukin-4 down regulates interleukin-6 production in human peripheral blood mononuclear cells. J Leuk Biol 47: 475–479Google Scholar
  66. 66.
    Leary AG, Ikebuchi K, Hirai Y, Wong GG, Yang YC, Clark SC, Ogawa M (1988) Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha. Blood 71: 1759–1763Google Scholar
  67. 67.
    Lindemann A, Ganser A, Hoelzer D, Mertelsmann R, Herrmann F (1991) In vivo administration of recombinant human interleukin-3 elicits an acute phase response involving endogenous synthesis of interleukin-6. Ann Intern Med (in press)Google Scholar
  68. 68.
    Loppnow H, Libby P (1990) Proliferating or interleukin-1-activated human vascular smooth muscle cells screte copious interleukin-6. J Clin Invest 85: 731–738Google Scholar
  69. 69.
    Lotem J, Shabo Y, Sachs L (1989) Regulation of megakaryocyte development by interleukin-6. Blood 74: 1545–1551Google Scholar
  70. 70.
    Lorre K, Van Damme J, Verwilghen J, Baroja ML, Ceuppens JL (1990) IL-6 is an accessory signal in the alternative CD2-mediated pathway of T-cell activation. J Immunol 144: 4681–4687Google Scholar
  71. 71.
    Lübbert M, Oster W, McComick F, Mertelsmann R, Herrmann F (1991) Clonal analysis of N-ras gene activation in acute myeloid leukemia. J Clin Invest (in press)Google Scholar
  72. 72.
    Lübbert M, Brach M, Mertelsmann R, Herrmann F (1991) Interleukin-6 inhibits growth of plasma cell neoplasms due to suppression of endogenous interleukin-6. Blood (in press)Google Scholar
  73. 73.
    Luger TA, Schwarz T, Krutmann J, Kirnbauer R, Neuner P, Kock A, Urbanski A, Borth W, Schauer E (1989) Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells: regulation of the acute phase and immune responses. Ann NY Acad Sci 557: 405–414Google Scholar
  74. 74.
    Luger TA, Krutman J, Kirnbauer R, Urbanski A, Schwarz T, Klappacher G, Köck A, Micksche M, Malejczyk J, Schauer E, May LT, Sehgal PB (1989) IFNβ2/IL-6 augments the activity of human natural killer cells. J Immunol 143: 1206–1209Google Scholar
  75. 75.
    Mantovani L, Henschler R, Brach MA, Wieser R, Lübbert M, Lindemann A, Mertelsmann R, Herrmann F (1990) Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxin. FEBS Lett 270: 152–156Google Scholar
  76. 76.
    Matsuda T, Hirano T, Kishimoto T (1988) Establishment of a interleukin-6 dependent cell line and preparation of anti-IL-6 monoclonal antibodies. Eur J Immunol 18: 951–956Google Scholar
  77. 77.
    Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T (1989) Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal carcinomas. FEBS Lett 250: 607–610Google Scholar
  78. 78.
    Miles SA, Rezai AR, Salazar-Gonzales JF, Van der Meyden M, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, Martinez-Maza O (1990) AIDS Kaposi sarcomaderived cells produce and respond to interleukin-6. Proc Natl Acad Sci USA 87: 4068–4072Google Scholar
  79. 79.
    Morinaga Y, Suzuki H, Takatsuki F, Akiyama Y, Taniyama T, Matsushima K, Onozaki K (1989) Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines. J Immunol 143: 3538–3542Google Scholar
  80. 80.
    Moshage HJ, Roelofs HNJ, Van Pelt JF, Hazenberg BPC, Van Leewen MA, Limburg PC, Aarden LA, Yap SH (1988) The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Comm 155: 112–117Google Scholar
  81. 81.
    Mule JJ, McIntosh JK, Jablons DM, Rosenberg SA (1990) Antitumor activity of recombinant interleukin-6 in mice. J Exp Med 171: 629–636Google Scholar
  82. 82.
    Musso T, Espinoza-Delgado J, Pulkki K, Gussela GL, Longo DL, Varesio L (1990) Transforming growth factor beta downregulates interleukin-1-induced IL-6 production by human monocytes. Blood 76: 2466–2469Google Scholar
  83. 83.
    Nagasawa T, Orita T, Matsushita J, Tsuchiya M, Neichi T, Imazeki I, Imai N, Ochi N, Kanma H, Abe T (1990) Thrombopoietic activity of human interleukin-6. FEBS Lett 260: 176–178Google Scholar
  84. 84.
    Nijsten MWN, De Groot ER, Ten Duis HJ, Klasen HJ, Hack CE, Aarden LA (1987) Serum levels of interleukin-6 and acute phase responses. Lancet 2: 921Google Scholar
  85. 85.
    Oster W, Cicco NA, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann R, Herrmann F (1989) Participation of the cytokines interleukin-6, tumor necrosis factor-alpha, and interleukin-1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest 84: 451–457Google Scholar
  86. 86.
    Poli G, Bressler P, Kinter T, Duh E, Timmer WC, Rabson A, Justement S, Stanley S, Fauci AS (1990) Interleukin-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and posttranscriptional mechanisms. J Exp Med 172: 151–158Google Scholar
  87. 87.
    Pullicino EA, Carli F, Poole S, Rafferty B, Malik STA, Elia M (1990) The relationship between the circulating concentrations of interleukin-6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphok Res 9: 2–6Google Scholar
  88. 88.
    Rennick D, Jackson J, Yang G, Wideman J, Lee F, Hudak S (1989) Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythoid, myeloid and multipotential progenitor cells. Blood 73: 1828–1835Google Scholar
  89. 89.
    Revel M, Chen L, Novivk D, Shulman LM, Gotthelf Y, Cohen B, Raber J, Chebath J, Michaelevicz R (1990) The growthpromoting, differentiative and cytostatic properties of interleukin-6. Proc Am Assoc Canc Res 31: 499–505Google Scholar
  90. 90.
    Romero R, Avila C, Santhanam U, Sehgal PB (1990) Amniotic fluid interleukin-6 in preterm labor. J Clin Invest 85: 1392–1400Google Scholar
  91. 91.
    Rose-John S, Schooltink H, Lenz D, Hipp E, Dufhues G, Schmitz H, Schiel X, Hirano T, Kishimoto T, Heinrich PC (1990) Studies on the structure and regulation of the human hepatic interleukin-6 receptor. Eur J Biochem 190: 79–83Google Scholar
  92. 92.
    Sachs L, Lotem J, Shabo Y (1989) The molecular regulators of macrophage and granulocyte development. Ann NY Acad Sci 557: 417–437Google Scholar
  93. 93.
    Shabo Y, Lotem J, Sachs L (1989) Autoregulation of interleukin-6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemia cells. Mol Cell Biol 9: 4109–4112Google Scholar
  94. 94.
    Shenkin A, Fraser WD, Series J, Winstanley FP, McCartney AC, Burns HJG, Van Damme J (1989) The serum interleukin-6 response to elective surgery. Lymphok Res 8: 123–127Google Scholar
  95. 95.
    Siegall CB, Chaudhary VK, Fitzgerald DJ, Pastan I (1988) Cytotoxic activity of an interleukin-6-Pseudomonas exotoxin fusion protein on human myeloma cells. Proc Natl Acad Sci USA 85: 9738–9742Google Scholar
  96. 96.
    Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi J, Van Damma E, Mantovani A (1989) IL-1 stimulates IL-6 production in endothelial cells. J Immunol 142: 549–553Google Scholar
  97. 97.
    Smyth MJ, Ortaldo JR, Bere W, Yagita H, Okumura K, Young HA (1990) IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol 145: 1159–1166Google Scholar
  98. 98.
    Suzuki C, Okano A, Takatsuki F, Miyasaka Y, Hirano T, Kishimoto T, Ejima D, Akiyama Y (1989) Continuous perfusion with interleukin-6 enhances production of hematopoietic stem cells (CFU-S). Biochem Biophys Res Commun 159: 933–938Google Scholar
  99. 99.
    Bender S, Haubeck HD, Van de Leur E, Dufhues G, Schiel X, Lauweriins J, Greiling H, Heinrich PC (1990) Interleukin-1 β induces synthesis and secreation of interleukin-6 in human chondrocytes. FEBS Lett 263: 321–324Google Scholar
  100. 100.
    Tabibzadeh SS, Poubouridis D, May LT, Sehgal PB (1991) Interleukin-6 immunoreactivity in human tumors. Am J -Pathol (in press)Google Scholar
  101. 101.
    Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Sehgal PB (1989) Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma. J Exp Med 170: 1649–1669Google Scholar
  102. 102.
    Te Velde AA, Huijbens RJF, Heije K, des Vries JE, Figdor CG (1990) Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor-alpha and IL-6 by monocytes. Blood 76: 1392–1397Google Scholar
  103. 103.
    Tosato G, Miller J, Marti G, Pike SE (1990) Accessory function of interleukin-1 and interleukin-6: preferential costimulation of T4-positive lymphocytes. Blood 75: 922–930Google Scholar
  104. 104.
    Utsumi K, Takai Y, Tada T, Ohzeki S, Fujiwara H, Hamaoka T (1990) Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production. J Immunol 145: 397–403Google Scholar
  105. 105.
    van der Schoot CE, Jansen P, Poorter M, Wester MR, Kr. von dem Borne AEG, Aarden LA, von Oers RHJ (1989) Interleukin-6 and interleukin-1 production in acute myeloid leukemia with monocytoid differentiation. Blood 74: 2081–2087Google Scholar
  106. 106.
    van Oers MHJ, van der Heyden AAPAM, Aarden LA (1988) Interleukin-6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 71: 314–319Google Scholar
  107. 107.
    van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Rubira MR, Simpson RJ (1986) Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83: 9679–9684Google Scholar
  108. 108.
    Yasukawa K, Hirano T, Watanabe Y, Murutoni K, Matsuda T, Nakai S, Kishimoto T (1987) Structure and expression of human B-cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J 6: 2939–2945Google Scholar
  109. 109.
    Yoshizaki K, Nakagawa T, Fukunaga K, Tseng LT, Yamamura Y, Kishimoto T (1984) Isolation and characterization of B-cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. J Immunol 132: 2948–2954Google Scholar
  110. 110.
    Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahate T, Kawai H, Tagoh H, Komori T, Kishimoto S, Hirano T, Kishimoto S (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74: 1360–1367Google Scholar
  111. 111.
    Zhang XG, Klein B, Bataille R (1989) Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 74: 11–13Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • J. Bauer
    • 1
  • F. Herrmann
    • 1
  1. 1.Psychiatrische Universitätsklinik und Medizinische Universitätsklinik (Abteilung Innere Medizin 1)Universität FreiburgFreiburgFRG

Personalised recommendations